| PID_in_paper | age(yr) | gender | race/ethnicity | infection_duration | pre_ART_duration | ART | ART_duration | pre_suppression_duration | suppression_duration | proviral_DNA_copies_at_sampling | viral_RNA_copies_at_sampling | suppression_status | CD4_at_sampling | sample_comment |
|---|
| F07.01 | 59(yr) | M | African American | | | ABC,3TC,EFV | 19(yr)(month) | | | | 52 (cps/mL)(copies/mL) | supressed | 1023(cells/mm3)(cells/ul) | low level viremia at sampling |
| C02.01 | 62(yr) | M | African American | | | TDF,FTC,EFV | 18(yr)(month) | | | | 184(cps/mL)(copies/mL) | supressed | 1022(cells/mm3)(cells/ul) | low level viremia at sampling |
| C03.02 | 42(yr) | M | white | | | DRV,r, ETV,DTG | 9(yr)(month) | | | | 62(cps/mL)(copies/mL) | supressed | 416(cells/mm3)(cells/ul) | low level viremia at sampling |
| R09.01 | 73(yr) | M | white | | | TDF,FTC,EFV | 10(yr)(month) | | | | 197(cps/mL)(copies/mL) | supressed | 380(cells/mm3)(cells/ul) | low level viremia at sampling |
| C03.01 | 42(yr) | M | white | | | DRV,r, ETV,DTG | 9(yr)(month) | | | | 62(cps/mL)(copies/mL) | supressed | 416(cells/mm3)(cells/ul) | low level viremia at sampling |
| C02.02 | 62(yr) | M | African American | | | TDF,FTC,EFV | 18(yr)(month) | | | | 184(cps/mL)(copies/mL) | supressed | 1022(cells/mm3)(cells/ul) | low level viremia at sampling |
| R09.02 | 73(yr) | M | white | | | TDF,FTC,EFV | 10(yr)(month) | | | | 197(cps/mL)(copies/mL) | supressed | 380(cells/mm3)(cells/ul) | low level viremia at sampling |
| F07.02 | 59(yr) | M | African American | | | ABC,3TC,EFV | 19(yr)(month) | | | | 52 (cps/mL)(copies/mL) | supressed | 1023(cells/mm3)(cells/ul) | low level viremia at sampling |
